Professor Thum and IMTTS team received Desmond Julian Award
August 2022 - Professor Dr. Dr. Thomas Thum and IMTTS team were awarded for their paper on a novel antisense therapy targeting microRNA-132 in heart failure.
July 2022 - Our article about circular RNAs as novel therapeutic strategy against doxorubicin-induced cardiotoxicity was selected as a research highlight.